Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Clinical trial NCT03044977 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03044977
Sponsor: David Bushnell
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Neuroendocrine Tumor, Malignant Neuroendocrine Tumor Gastrointestinal, Hormone-Secreting

Start date: 2017-05-07
Primary completion: 2025-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.